Takotsubo cardiomyopathy, also known as transient left ventricular apical ballooning syndrome, is an increasingly recognized differential diagnosis among postmenopausal women with symptoms of an acute myocardial infarction following an abrupt psychological or physical stressor. Although pathophysiology remains unclear, suspicion of catecholamine mediated myocardial stunning is highly favored as myocardial function returns to normal within days to a few weeks. Treatment is aimed at supportive measures including reducing anxiety, alleviating pain, maintaining heart contractility, monitoring fluid balance, and preventing and treating complications.
INTRODUCTION
Takotsubo cardiomyopathy also known as transient left ventricular apical ballooning syndrome, ampulla cardiomyopathy, stress-induced cardiomyopathy, hypocatecholamine-induced acute myocardial stunning, and broken heart syndrome is an acute reversible cardiomyopathy characterized by transient regional wall motion abnormalities of the left ventricular mid segments with or without apical involvement and hyperkinesis of the basal segments.(1) Takotsubo cardiomyopathy is an increasingly recognized differential diagnosis among postmenopausal women with suspected acute coronary syndromes following an abrupt psychological or physical stressor.(2) Takotsubo cardiomyopathy was first described in the early 1990s in Japan and named for the Japanese fishing pot with a narrow neck and a wide base used to trap octopus ( 
CASE STUDY
Ms. L, 79 year old Caucasian female presented to the emergency department (ED) after sudden onset of severe midsternal, nonradiating chest pain occurring about 45 minutes prior to arrival. While teaching Sunday school, the patient reportedly became quite "flushed" and "excited" during an intense religious discussion. She reported dizziness, slight nausea, diaphoresis, and palpitations ("I thought I would faint"). She acknowledged having had these similar symptoms prior to hospitalization. Medical personnel reported chest pain resolution just prior to ED arrival. The patient's past medical history included hypertension, supraventricular tachycardia and paroxysmal atrial fibrillation with failed ablation, transient ischemic attack, hyperlipidemia, gastroesophageal reflux disease and frequent anxiety reactions. Home medications were warfarin, lisinopril, amiodarone, omeprazole, hydrochlorothiazide, simvastatin, tramadol, carvedilol, calcium and multiple vitamins. Her three children and families did not visit but one to two times yearly, and had not done so since her husband passed away six months prior. She was immediately supported only by her "church family" and friends.
Ms. L was admitted to the intensive care unit. Routine cardiac care was initiated for an acute coronary syndrome. Serial cardiac biomarkers elevated with troponin I (4.2) and creatinine kinase/MB (469/48). Serial electrocardiograms revealed sinus rhythm with first degree atrioventricular block and nondiagnostic T-wave inversion in lead III. Chest x-ray was normal. Home medications were continued except warfarin. Intravenous vitamin K was administered to reverse an international normalized ratio of 2.7. The following morning she was taken for cardiac catheterization. Coronary angiography with left ventriculogram revealed no obstructive coronary artery disease (Figure 2 ), no mitral regurgitation, left ventricular end-diastolic pressure 22 mmHg, ejection fraction 40% and a large apical akinetic segment ( Figure 3 ). The patient was diagnosed with Takotsubo cardiomyopathy. The frequent occurrence in postmenopausal women has not been explained, but changes in autonomic control of the cardiovascular system and in baroreceptor sensitivity have been suspected.(6) Lavi et al. (7) added that cardiac vagal tone and baroreflex sensitivity decreased significantly in postmenopausal women. Furthermore, cardiovascular betaadrenoreceptor responsiveness decreased and alpha 1-adrenoreceptor responsiveness increased yielding sympathetic dominance to replace parasympathetic dominance as the main regulator of the cardiovascular system. (7) Changes would be associated with acute stress and include heart rate increases and vasoconstriction. (6) Wilkinson et al. (8) noted epinephrine was released from the heart at rest and during spontaneous panic attacks. Epinephrine and norepinephrine samples obtained from the coronary sinus during panic episodes have demonstrated reduced extraction of norepinephrine and epinephrine during transit through the heart.(9, 10) Norepinephrine transporter impairment limits catecholamine effects on the heart and has the potential to increase cardiac responses to catecholamine surges during panic attacks and other stressful events. Patients with Takotsubo cardiomyopathy have local release of catecholamines in myocardial tissue. (6) Therefore, the most favorable pathogenesis to Takotsubo cardiomyopathy development is direct myocardial injury caused by catecholamine medicated myocardial stunning.(3) Direct myocyte injury occurs through formation of oxygendeprived free radicals which decrease myocyte viability. Free radicals interfere with sodium and calcium transporters increasing calcium influx, thus cellular calcium overload. (3) Mononuclear inflammatory infiltrates and myocyte necrosis occurs and can be depicted by myocardial tissue biopsy. Adrenoceptor density is higher in the cardiac apex compared with other areas of the myocardium accounting for apical and mid left ventricular contractile abnormalities. Basal segments are spared giving the distinctive shape noted on ventriculography.(3)
INCIDENCE, PREVALENCE AND MORTALITY
The prevalence of Takotsubo cardiomyopathy is estimated to range between 0.7 to 2.5%. 
CLINICAL PRESENTATION
The diagnosis of Takotsubo cardiomyopathy is confirmed by presence of all four Mayo Clinic diagnostic criteria: transient contractile dysfunction of the mid-left ventricular segments with or without apical involvement, extending beyond a single epicardial vascular distribution; absence of obstructive coronary disease or angiographic evidence of acute plaque rupture; new electrocardiographic abnormalities (either STsegment elevation, T-wave inversion, or both) or elevated cardiac troponin; and the absence of a pheochromocytoma or myocarditis. (12) The most common symptom associated with Takotsubo cardiomyopathy presentation is a severe sudden onset of substernal chest pain after an acute emotional or physical stressor.(12) Dyspnea, syncope and palpitations have also been described. Takotsubo cardiomyopathy mimics an acute coronary syndrome in 
MANAGEMENT AND IMPLICATIONS TO ADVANCED PRACTICE NURSING
Supportive measures comprise the cornerstone of pharmacological and mechanical therapy in the treatment of Takotsubo cardiomyopathy. The majority of patients are initially treated as an acute anterior wall myocardial infarction or acute coronary syndrome, as cardiac biomarkers and electrocardiographic changes may be present.(1) Prompt recognition of left ventricular apical ballooning is needed to prevent unnecessary use of fibrinolytic agents, such as tissue plasmogen activators. (1) Fibrinolytic agents may cause serious bleeding disorders, cholesterol embolism, cardiogenic shock, heart failure, pericardial effusion, myocardial rupture and electromechanical dissociation.(36) Patients are typically prescribed aspirin, beta blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, and statins. (14) Calcium channel antagonists and nitrates are also prescribed. (14, 27) Patient symptoms vary from mildly symptomatic to critically ill. (28) The advanced practice nurse (APN) must be prepared to address common complications of Takotsubo cardiomyopathy including heart failure, pulmonary edema, dynamic outflow tract obstruction and cardiogenic shock. (11, 12) Emergent coronary angiograms are frequently performed by the interventional cardiologist to definitively diagnose left ventricular apical ballooning syndrome. Twenty-percent of patients require the insertion of an intraaortic balloon pump (27, 28) to decrease left ventricular workload, decrease afterload, improve contractility and increase stroke volume. (29) The APN may be required to initiate dobutamine or milrinone intravenous therapy as inotropic support of left ventricular failure.(28) Diuretics are given for heart failure and pulmonary edema. Pulmonary artery and/or arterial catheters may be inserted to assist in monitoring hemodynamic stability including cardiac output and cardiac index. 
CONCLUSION
Ms. L's warfarin was resumed and all previous home medications were continued at discharge. She followed two weeks later in the out-patient cardiology clinic with the APN. Transthoracic echocardiography was performed revealing a 65% ejection fraction and complete resolution of prior large apical akinetic segment. She denied any return of previous signs and symptoms of heart failure or chest pain. The left ventricular apical ballooning appearance of Takotsubo cardiomyopathy had resolved.
Takotsubo cardiomyopathy is an important entity to be recognized by the APN. (35) Differential diagnosis should be considered among postmenopausal women presenting with characteristic signs and symptoms of an acute coronary syndrome after an emotional or physical stressor. (2) STsegment changes (21) and cardiac biomarker elevations (1) may or may not be evident. Coronary angiography typically reveals no significant coronary lesions to account for the marked left ventricular wall motion abnormalities. (12) The left ventricular apical ballooning is transient and the majority of patient myocardial function returns to normal within days to a few weeks. (19) The APN should aim treatment goals at reducing anxiety, alleviating pain, maintaining contractility, monitoring fluid balance and preventing and treating complications. (29) With supportive care, prognosis is favorable. (1, 3) 
